Senior Director, Corporate Strategy

Takeda•Boston, MA

1d•$212,000 - $333,190•Hybrid

About The Position

The Senior Director, Corporate Strategy leads critical components of Takeda’s corporate strategy function, helping align corporate, portfolio, and functional strategies and enterprise resource allocation with scientific innovation, commercial excellence, and patient impact. Reporting to the Head of Corporate Strategy, the role partners with senior leaders across Strategy & Portfolio Development, R&D, commercial business units, finance, External Portfolio Innovation, and other functions to evaluate enterprise priorities, frame strategic choices, and develop recommendations that support sustainable growth and competitive advantage. The role leads major enterprise strategy initiatives, scenario planning, strategic alternatives evaluation, industry and competitive benchmarking, and strategic assessments of acquisitions, divestitures, and other corporate development opportunities. It also develops strategic evaluations and decision materials for the Takeda Executive Team and Board of Directors. The position is based in Cambridge, Massachusetts, is hybrid, and involves approximately 15% global travel.

Requirements

10+ years of experience in corporate strategy, portfolio strategy, management consulting, business development, investment banking, or related roles, with significant experience in the pharmaceutical or biotech industry.
Proven and progressive track record leading complex corporate strategy, portfolio, growth strategy, or corporate development initiatives.
Experience working in a global, matrixed organization and leading cross-functional teams without direct authority.
BA/BS degree required.
Ability to structure and solve complex, ambiguous strategic questions and translate extensive qualitative and quantitative information into clear recommendations.
Demonstrated experience leading scenario planning, evaluating strategic alternatives, and articulating the implications of uncertainty for enterprise choices.
Strong understanding of the global biopharma industry, including R&D, commercialization, portfolio management, business development, market access, healthcare policy, and industry economics.
Strong financial and business acumen, including understanding of valuation, capital allocation, financial statements, risk-adjusted returns, and enterprise value creation.
Ability to assess emerging technologies and external developments, including AI, digital health, geopolitical change, regulatory developments, and evolving business models.
Exceptional written and verbal communication skills, including developing succinct, compelling materials for executive leadership and the Board.
Executive presence and credibility to advise, influence, and appropriately challenge senior leaders.
Strong facilitation and stakeholder-management skills, with the ability to build alignment across functions, cultures, therapeutic areas, and geographies.
Demonstrated ability to lead multiple high-priority strategy initiatives while maintaining analytical rigor, attention to detail, and responsiveness to changing priorities.
Ability to translate strategy into measurable outcomes and support implementation, appropriately leveraging AI and technology to accelerate results.
Based in Cambridge, MA, with approximately 15% global travel expected.

Nice To Haves

MBA, PhD, MD, or equivalent advanced degree strongly preferred.

Responsibilities

Lead major components of the company’s long-term corporate strategy across therapeutic areas and geographies, translating enterprise ambitions into strategic choices, priorities, and actions.
Lead enterprise scenario planning and strategic foresight, evaluating strategic pathways under potential industry, market, policy, geopolitical, scientific, and technology scenarios.
Frame complex enterprise decisions by defining alternatives, evaluating implications and trade-offs, and developing evidence-based recommendations for senior leadership.
Lead analysis of major corporate strategic decisions and develop executive summaries, evaluations, and decision materials for the Takeda Executive Team and Board of Directors.
Conduct industry and peer benchmarking of relative performance, portfolio strategies, investment patterns, operating models, capabilities, and competitive advantage.
Evaluate the evolution of business models in biopharma and the broader healthcare ecosystem, including implications of AI, digital health, scientific innovation, geopolitical conditions, healthcare policy, and emerging innovation ecosystems.
Lead strategic evaluations of mergers and acquisitions, divestitures, and other corporate development opportunities, assessing strategic fit, enterprise value creation, portfolio implications, risks, and alternatives.
Lead cross-functional strategy projects addressing enterprise growth, portfolio priorities, geographic and market expansion, capability requirements, and other high-impact strategic questions.
Support annual strategic planning to ensure business unit, therapeutic area, portfolio, and functional strategies align with the company’s long-term direction.
Monitor global biopharma trends, competitive dynamics, capital-market developments, regulatory and policy changes, and potential disruptions, translating them into actionable implications for Takeda.
Develop clear, concise presentations, strategic narratives, and executive communications for senior leadership and the Board.
Build alignment among senior stakeholders with differing perspectives and facilitate structured discussions about strategic options, assumptions, risks, and trade-offs.
Apply AI, advanced analytics, and emerging technology tools to improve the speed, rigor, and range of strategic analysis while maintaining quality, judgment, and confidentiality.
Guide and develop strategy professionals and raise the quality of analysis, problem-solving, and executive communication across a team.
Translate strategy into measurable outcomes and support implementation, appropriately leveraging AI and technology to accelerate results.